Page 135 - 南京医科大学自然版

第45卷第7期 季彦君，唐立钧. PET显像剂在多发性骨髓瘤中的应用和进展［J］.
2025年7月 南京医科大学学报（自然科学版），2025，45（7）：1026-1034 ·1033 ·

18
18
et al. Comparison of F ⁃ sodium fluoride uptake in the tial evaluation of F⁃FACBC for PET imaging of multiple
whole bone，pelvis，and femoral neck of multiple myelo⁃ myeloma［J］. EJNMMI Res，2022，12（1）：4
ma patients before and after high⁃dose therapy and con⁃ ［49］STOKKE C，NORGAARD J N，FEIRING P H，et al. Com⁃
18
18
ventional⁃dose chemotherapy［J］. Eur J Nucl Med Mol Im⁃ parison of F fluciclovine and F⁃FDG PET/CT in newly
aging，2020，47（12）：2846-2855 diagnosed multiple myeloma patients［J］. Mol Imaging Bi⁃
［38］ZADEH M Z，SERAJ S M，OSTERGAARD B，et al. Prog⁃ ol，2022，24（5）：842-851
18
11
nostic significance of F⁃sodium fluoride in newly diag⁃ ［50］NANNI C，ZAMAGNI E，CAVO M，et al. C⁃choline vs.
nosed multiple myeloma patients［J］. Am J Nucl Med 18 F ⁃ FDG PET/CT in assessing bone involvement in pa⁃
Mol Imaging，2020，10（4）：151-160 tients with multiple myeloma［J］. World J Surg Oncol，
18
18
［39］TZOLOS E，DWECK M R. F⁃sodium fluoride F⁃NaF for 2007，5：68
11
imaging microcalcification activity in the cardiovascular ［51］LAPA C，KIRCHER M，DA V M，et al. Comparison of C⁃
system［J］. Arterioscler Thromb Vasc Biol，2020，40（7）： Choline and C⁃Methionine PET/CT in multiple myelo⁃
11
1620-1626 ma［J］. Clin Nucl Med，2019，44（8）：620-624
［40］ARANI L S，ZIRAKCHIAN Z M，SABOURY B，et al. As⁃ ［52］CASSOU⁃MOUNAT T，BALOGOVA S，NATAF V，et al.
18
sessment of atherosclerosis in multiple myeloma and smol⁃ 18 F⁃fluorocholine versus F⁃fluorodeoxyglucose for PET/CT
18
dering myeloma patients using F⁃ sodium fluoride PET/ imaging in patients with suspected relapsing or progres⁃
CT［J］. J Nucl Cardiol，2021，28（6）：3044-3054 sive multiple myeloma：a pilot study［J］. Eur J Nucl Med
［41］王 铃，梁 艳，周 丽. 免疫调节剂治疗多发性骨髓 Mol Imaging，2016，43（11）：1995-2004
瘤相关血栓事件［J］. 南京医科大学学报（自然科学 ［53］CALABRIA F，CHIARAVALLOTI A，CICCIO C，et al.
18
版），2019，39（12）：1761-1763 PET/CT with F⁃choline：physiological whole bio⁃distribu⁃
WANG L，LIANG Y，ZHOU L. Immunomodulator therapy tion in male and female subjects and diagnostic pitfalls
18
for multiple myeloma associated thrombotic events［J］. on 1000 prostate cancer patients： F⁃choline PET/CT bio⁃
Journal of Nanjing Medical University（Natural Science distribution and pitfalls. a southern italian experience［J］.
Edition），2019，39（12）：1761-1763 Nucl Med Biol，2017，51：40-54
11
［42］MINAMIMOTO R. Amino acid and proliferation PET/CT ［54］HO C L，CHEN S，LEUNG Y L，et al. C⁃acetate PET/CT
for the diagnosis of multiple myeloma［J］. Front Nucl for metabolic characterization of multiple myeloma：a
18
Med，2022，1：796357 comparative study with F⁃FDG PET/CT［J］. J Nucl Med，
［43］NAKAMOTO Y，KURIHARA K，NISHIZAWA M，et al. 2014，55（5）：749-752
11
Clinical value of C⁃methionine PET/CT in patients with ［55］WAKUI M，TSUCHIYA J，KASE C，et al. Comparative
18
plasma cell malignancy：comparison with F⁃FDG PET/CT study of metabolic tumor volume in multiple myeloma and
18
11
［J］. Eur J Nucl Med Mol Imaging，2013，40（5）：708-715 related plasma cell dyscrasias： C ⁃ Acetate PET vs. F ⁃
［44］LAPA C，GARCIA⁃VELLOSO M J，LUCKERATH K，et FDG PET［J］. Cureus，2024，16（10）：e71605
11
11
al. C⁃Methionine⁃PET in multiple myeloma：a combined ［56］CHEN M，ZHU W，DU J，et al. C⁃acetate positron emis⁃
study from two different institutions［J］. Theranostics， sion tomography is more precise than 18F⁃fluorodeoxyglu⁃
2017，7（11）：2956-2964 cose positron emission tomography in evaluating tumor
［45］MORALES⁃LOZANO M I，VIERING O，SAMNICK S，et burden and predicting disease risk of multiple myeloma［J］.
18
11
al. F⁃FDG and C⁃methionine PET/CT in newly diag⁃ Sci Rep，2021，11（1）：22188
nosed multiple myeloma patients：comparison of volume⁃ ［57］WANG C，CHEN Y，HOU Y N，et al. ImmunoPET imag⁃
68
based PET biomarkers［J］. Cancers（Basel），2020，12 ing of multiple myeloma with Ga⁃Ga⁃NOTA⁃Nb1053［J］.
（4）：1042 Eur J Nucl Med Mol Imaging，2021，48（9）：2749-2760
［46］LUCKERATH K，LAPA C，SPAHMANN A，et al. Target⁃ ［58］ULANER G A，SOBOL N B，O’DONOGHUE J A，et al.
ing paraprotein biosynthesis for non⁃invasive characteriza⁃ CD38⁃targeted immuno⁃PET of multiple myeloma：from
tion of myeloma biology［J］. PLoS One，2013，8（12）： xenograft models to first⁃in⁃human imaging［J］. Radiolo⁃
e84840 gy，2020，295（3）：606-615
18
［47］CZYZ J，MALKOWSKI B，JURCZYSZYN A，et al. F⁃flu⁃ ［59］GHAI A，MAJI D，CHO N，et al. Preclinical development
18
89
oro⁃ethyl⁃tyrosine F⁃FET PET/CT as a potential new of CD38⁃Targeted Zr⁃Zr⁃DFO⁃daratumumab for imaging
diagnostic tool in multiple myeloma：a preliminary study multiple myeloma［J］. J Nucl Med，2018，59（2）：216-222
［J］. Contemp Oncol（Pozn），2019，23（1）：23-31 ［60］BAILLY C，GOUARD S，LACOMBE M，et al. Comparison
［48］MORATH V，HEIDER M，MITTELHAUSER M，et al. Ini⁃ 64
of immuno⁃PET of CD138 and PET imaging with CuCl2